Eloralintide And Tirzepatide
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
Eli Lilly · Phase 1 · Completed · Enrollment 188
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.